BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16336511)

  • 1. The short QT syndrome as a paradigm to understand the role of potassium channels in ventricular fibrillation.
    Cerrone M; Noujaim S; Jalife J
    J Intern Med; 2006 Jan; 259(1):24-38. PubMed ID: 16336511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and molecular genetics of the short QT syndrome.
    Schimpf R; Borggrefe M; Wolpert C
    Curr Opin Cardiol; 2008 May; 23(3):192-8. PubMed ID: 18382206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital short QT syndrome. A review.
    Ginghină C; Ciudin R; Lăpuşanu O; Kulcsar I; Selaru A; Gherasim D
    Rom J Intern Med; 2005; 43(3-4):165-72. PubMed ID: 16812977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short QT syndrome. Update on a recent entity.
    Maury P; Extramiana F; Sbragia P; Giustetto C; Schimpf R; Duparc A; Wolpert C; Denjoy I; Delay M; Borggrefe M; Gaita F
    Arch Cardiovasc Dis; 2008; 101(11-12):779-86. PubMed ID: 19059573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel gain-of-function KCNJ2 mutation associated with short-QT syndrome impairs inward rectification of Kir2.1 currents.
    Hattori T; Makiyama T; Akao M; Ehara E; Ohno S; Iguchi M; Nishio Y; Sasaki K; Itoh H; Yokode M; Kita T; Horie M; Kimura T
    Cardiovasc Res; 2012 Mar; 93(4):666-73. PubMed ID: 22155372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of early repolarization in short QT syndrome.
    Watanabe H; Makiyama T; Koyama T; Kannankeril PJ; Seto S; Okamura K; Oda H; Itoh H; Okada M; Tanabe N; Yagihara N; Kamakura S; Horie M; Aizawa Y; Shimizu W
    Heart Rhythm; 2010 May; 7(5):647-52. PubMed ID: 20206319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Short QT Syndromes].
    Schulze-Bahr E
    Herz; 2006 Apr; 31(2):118-22; quiz 142-3. PubMed ID: 16738834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Short QT syndrome as an inherited condition].
    Møller DV; Hedley PL; Olesen M; Kanters J; Svendsen JH; Christiansen M
    Ugeskr Laeger; 2011 Feb; 173(6):420-4. PubMed ID: 21299935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced ion currents and the endothelin pathway as targets for anti-arrhythmic agents.
    Dai DZ; Dai Y
    Curr Opin Investig Drugs; 2008 Sep; 9(9):1001-8. PubMed ID: 18729007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short QT syndrome: a very rare arrhythmogenic entity.
    Yontar OC; Yalta K; Yilmaz MB; Turgut OO
    Acta Cardiol; 2008 Oct; 63(5):553-5. PubMed ID: 19013996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes.
    Sala M; Coppa F; Cappucciati C; Brambilla P; d'Allio G; Caverzasi E; Barale F; De Ferrari GM
    Curr Opin Investig Drugs; 2006 Mar; 7(3):256-63. PubMed ID: 16555686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depolarization/repolarization, electrocardiographic abnormalities, and arrhythmias in cardiac channelopathies.
    Marcus FI
    J Electrocardiol; 2005 Oct; 38(4 Suppl):60-3. PubMed ID: 16226076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KCNJ2 variant of unknown significance reclassified as long QT syndrome causing ventricular fibrillation.
    Obeyesekere MN; Klein GJ; Conacher S; Krahn AD
    Can J Cardiol; 2011; 27(6):870.e11-3. PubMed ID: 21875779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sudden cardiac death: better understanding of risks, mechanisms, and treatment.
    Lopshire JC; Zipes DP
    Circulation; 2006 Sep; 114(11):1134-6. PubMed ID: 16966594
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of potassium currents in cardiac arrhythmias.
    Ravens U; Cerbai E
    Europace; 2008 Oct; 10(10):1133-7. PubMed ID: 18653669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic angiotensin II stimulation in the heart produces an acquired long QT syndrome associated with IK1 potassium current downregulation.
    Domenighetti AA; Boixel C; Cefai D; Abriel H; Pedrazzini T
    J Mol Cell Cardiol; 2007 Jan; 42(1):63-70. PubMed ID: 17070838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital short QT syndrome: landmarks of the newest arrhythmogenic cardiac channelopathy.
    Pérez Riera AR; Paixão-Almeida A; Barbosa-Barros R; Yanowitz FG; Baranchuk A; Dubner S; Palandri Chagas AC
    Cardiol J; 2013; 20(5):464-71. PubMed ID: 23677719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Heart hypertrophy and heart failure--experimental findings for arrhythmogenesis].
    Milberg P; Pott C; Eckardt L; Breithardt G
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S285-9. PubMed ID: 19085808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular/genetic determinants of repolarization and their modification by environmental stress.
    Rosen MR; Cohen IS
    J Intern Med; 2006 Jan; 259(1):7-23. PubMed ID: 16336510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.